Incorporating a brief intervention for personalised cancer risk assessment to promote behaviour change into primary care: a multi-methods pilot study.


Journal

BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562

Informations de publication

Date de publication:
23 01 2021
Historique:
received: 22 04 2020
accepted: 10 01 2021
entrez: 24 1 2021
pubmed: 25 1 2021
medline: 15 5 2021
Statut: epublish

Résumé

Approximately 40% of cancers could be prevented if people lived healthier lifestyles. We have developed a theory-based brief intervention to share personalised cancer risk information and promote behaviour change within primary care. This study aimed to assess the feasibility and acceptability of incorporating this intervention into primary care consultations. Patients eligible for an NHS Health Check or annual chronic disease review at five general practices were invited to participate in a non-randomised pilot study. In addition to the NHS Health Check or chronic disease review, those receiving the intervention were provided with their estimated risk of developing the most common preventable cancers alongside tailored behaviour change advice. Patients completed online questionnaires at baseline, immediately post-consultation and at 3-month follow-up. Consultations were audio/video recorded. Patients (n = 12) and healthcare professionals (HCPs) (n = 7) participated in post-intervention qualitative interviews that were analysed using thematic analysis. 62 patients took part. Thirty-four attended for an NHS Health Check plus the intervention; 7 for a standard NHS Health Check; 16 for a chronic disease review plus the intervention; and 5 for a standard chronic disease review. The mean time for delivery of the intervention was 9.6 min (SD 3) within NHS Health Checks and 9 min (SD 4) within chronic disease reviews. Fidelity of delivery of the intervention was high. Data from the questionnaires demonstrates potential improvements in health-related behaviours following the intervention. Patients receiving the intervention found the cancer risk information and lifestyle advice understandable, useful and motivating. HCPs felt that the intervention fitted well within NHS Health Checks and facilitated conversations around behaviour change. Integrating the intervention within chronic disease reviews was more challenging. Incorporating a risk-based intervention to promote behaviour change for cancer prevention into primary care consultations is feasible and acceptable to both patients and HCPs. A randomised trial is now needed to assess the effect on health behaviours. When designing that trial, and other prevention activities within primary care, it is necessary to consider challenges around patient recruitment, the HCP contact time needed for delivery of interventions, and how best to integrate discussions about disease risk within routine care.

Sections du résumé

BACKGROUND
Approximately 40% of cancers could be prevented if people lived healthier lifestyles. We have developed a theory-based brief intervention to share personalised cancer risk information and promote behaviour change within primary care. This study aimed to assess the feasibility and acceptability of incorporating this intervention into primary care consultations.
METHOD
Patients eligible for an NHS Health Check or annual chronic disease review at five general practices were invited to participate in a non-randomised pilot study. In addition to the NHS Health Check or chronic disease review, those receiving the intervention were provided with their estimated risk of developing the most common preventable cancers alongside tailored behaviour change advice. Patients completed online questionnaires at baseline, immediately post-consultation and at 3-month follow-up. Consultations were audio/video recorded. Patients (n = 12) and healthcare professionals (HCPs) (n = 7) participated in post-intervention qualitative interviews that were analysed using thematic analysis.
RESULTS
62 patients took part. Thirty-four attended for an NHS Health Check plus the intervention; 7 for a standard NHS Health Check; 16 for a chronic disease review plus the intervention; and 5 for a standard chronic disease review. The mean time for delivery of the intervention was 9.6 min (SD 3) within NHS Health Checks and 9 min (SD 4) within chronic disease reviews. Fidelity of delivery of the intervention was high. Data from the questionnaires demonstrates potential improvements in health-related behaviours following the intervention. Patients receiving the intervention found the cancer risk information and lifestyle advice understandable, useful and motivating. HCPs felt that the intervention fitted well within NHS Health Checks and facilitated conversations around behaviour change. Integrating the intervention within chronic disease reviews was more challenging.
CONCLUSIONS
Incorporating a risk-based intervention to promote behaviour change for cancer prevention into primary care consultations is feasible and acceptable to both patients and HCPs. A randomised trial is now needed to assess the effect on health behaviours. When designing that trial, and other prevention activities within primary care, it is necessary to consider challenges around patient recruitment, the HCP contact time needed for delivery of interventions, and how best to integrate discussions about disease risk within routine care.

Identifiants

pubmed: 33485309
doi: 10.1186/s12889-021-10210-3
pii: 10.1186/s12889-021-10210-3
pmc: PMC7824918
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

205

Subventions

Organisme : Medical Research Council
ID : MC_UU_00006/6
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C55650/A21464
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C8640/A23385
Pays : United Kingdom

Références

Ann Behav Med. 2017 Oct;51(5):718-729
pubmed: 28290066
Prev Med. 2005 May;40(5):595-601
pubmed: 15749144
J Natl Cancer Inst Monogr. 1994;(16):171-6
pubmed: 7999461
BMC Fam Pract. 2013 Feb 09;14:20
pubmed: 23394162
J Public Health (Oxf). 2016 Sep;38(3):560-568
pubmed: 26036701
Eur J Cancer Care (Engl). 2014 May;23(3):288-99
pubmed: 24004198
Ann Intern Med. 1991 Apr 15;114(8):657-61
pubmed: 2003712
BMJ Open. 2018 Jan 23;8(1):e017717
pubmed: 29362249
Public Health Genomics. 2010;13(1):34-47
pubmed: 19407440
Br J Cancer. 2009 Dec 3;101 Suppl 2:S13-7
pubmed: 19956157
Ann Intern Med. 1997 Dec 1;127(11):966-72
pubmed: 9412301
Br J Clin Psychol. 1992 Sep;31(3):301-6
pubmed: 1393159
Psychol Health. 2009 Mar;24(3):333-50
pubmed: 20204997
Br J Gen Pract. 2018 Jan;68(666):e28-e35
pubmed: 29203682
BMC Public Health. 2020 Jan 21;20(1):93
pubmed: 31964366
J Pers Soc Psychol. 1987 Mar;52(3):596-604
pubmed: 3572727
Ann Behav Med. 2016 Oct;50(5):653-663
pubmed: 26961206
Prim Health Care Res Dev. 2020 Jan 14;21:e1
pubmed: 31934843
BMC Public Health. 2012 Jun 18;12:444
pubmed: 22708638
Br J Gen Pract. 2017 Mar;67(656):e218-e226
pubmed: 28193618
Aust J Prim Health. 2012;18(2):129-37
pubmed: 22551835
Health Expect. 2016 Apr;19(2):345-55
pubmed: 25732686
Prim Health Care Res Dev. 2015 May;16(3):316-21
pubmed: 25391284
Br J Gen Pract. 2018 Jul;68(672):e449-e459
pubmed: 29914882
BMC Fam Pract. 2013 May 07;14:58
pubmed: 23651706
PLoS One. 2016 Mar 15;11(3):e0150205
pubmed: 26978655

Auteurs

Katie Mills (K)

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Box 113 Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK.

Ben Paxton (B)

University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0SP, UK.

Fiona M Walter (FM)

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Box 113 Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK.

Simon J Griffin (SJ)

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Box 113 Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK.

Stephen Sutton (S)

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Box 113 Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK.

Juliet A Usher-Smith (JA)

The Primary Care Unit, Department of Public Health and Primary Care, University of Cambridge School of Clinical Medicine, Box 113 Cambridge Biomedical Campus, Cambridge, CB2 0SR, UK. jau20@medschl.cam.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH